Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).
Defining the clinical course of multiple sclerosis: the 2013 revisions
